Upstate Partners with CXR Biosciences
to Develop Drug-Screening Tests
Upstate Group, a Serologicals subsidiary, and CXR Biosciences plan to co-develop a series of in vitro tests to aid in the early-stage drug-discovery process, the companies said last week.
Upstate Group will partner with Dundee, Scotland-based CXR to develop the drug toxicity and metabolism screens to profile compounds in various cell-based and in vitro assays, the companies said.
Financial details were not disclosed.